Logo

Oklahoma Foundation Licenses DNAStar's Sequencing Software

May 06, 2008
NEW YORK (GenomeWeb News) – An Oklahoma City medical research non-profit organization has licensed DNAStar’s sequence analysis software, the company said Monday.
 
Under the site license agreement, the Oklahoma Medical Research Foundation will use DNAStar’s Lasergene software in its research into the causes and cures of heart disease, Alzheimer’s disease, cancer, and diabetes.
 
The Lasergene desktop software is used to perform assembly, visualization, and analysis functions on data from Sanger sequencing and high-throughput, next-generation sequencing projects. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.